Ordinary Rebalance | Solactive China Healthcare Disruption Index | Effective Date 1st March 2023
Solactive China Healthcare Disruption Index:
In the ordinary rebalance, effective open 01.03.2023 the following index composition was implemented:
| 3D MEDICINES INC | 1.1994 % |
| 3SBIO INC | 1.206 % |
| AKESO INC | 2.1382 % |
| ALIBABA HEALTH INFORMATION TECHNOLOGY LTD | 4.8125 % |
| ALPHAMAB ONCOLOGY | 0.8903 % |
| ANGELALIGN TECHNOLOGY INC | 1.1553 % |
| CANSINO BIOLOGICS INC | 1.2936 % |
| CHINA MEDICAL SYSTEM HOLDINGS LTD | 1.8389 % |
| CSPC PHARMACEUTICAL GROUP LTD | 6.3936 % |
| GENSCRIPT BIOTECH CORP | 2.8847 % |
| GIANT BIOGENE HOLDING CO LTD | 2.9659 % |
| GRAND PHARMACEUTICAL GROUP LTD | 1.0062 % |
| HANSOH PHARMACEUTICAL GROUP CO | 5.3073 % |
| INNOCARE PHARMA LTD | 1.0153 % |
| INNOVENT BIOLOGICS INC | 3.7159 % |
| JD HEALTH INTERNATIONAL INC | 8.4326 % |
| JOINN LABORATORIES CHINA C-H | 2.0505 % |
| KEYMED BIOSCIENCES INC | 1.1201 % |
| LIFETECH SCIENTIFIC CORP | 0.8593 % |
| LIVZON PHARMACEUTICAL GROUP INC | 2.1283 % |
| LUYE PHARMA GROUP LTD | 0.8144 % |
| MICROPORT SCIENTIFIC CORP | 2.5787 % |
| NEW HORIZON HEALTH LTD | 0.9538 % |
| PING AN HEALTHCARE AND TECHNOL | 1.2757 % |
| REMEGEN CO LTD-H | 2.6061 % |
| SHANDONG WEIGAO GROUP MEDICAL POLYMER CO LTD | 3.6388 % |
| SHANGHAI FOSUN PHARMACEUTICAL GROUP CO LTD | 5.8498 % |
| SHANGHAI HAOHAI BIOLOGICAL TECHNOLOGY CO LTD | 1.1768 % |
| SHANGHAI JUNSHI BIOSCIENCES CO LTD | 3.2008 % |
| SHANGHAI MICROPORT MEDBOT GR | 1.7668 % |
| SIMCERE PHARMACEUTICAL GROUP | 1.7247 % |
| SINO BIOPHARMACEUTICAL LTD ORD | 4.8428 % |
| WUXI APPTEC CO LTD | 7.7306 % |
| WUXI BIOLOGICS CAYMAN INC | 7.6776 % |
| ZAI LAB LTD | 1.7486 % |